Effect of Topiramate on Seizures and Respiratory Dysrhythmia in Rett Syndrome
Authors:
- 1 August 2004
- journal article
- other
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 19 (8) , 588-591
Abstract
Rett syndrome, a neurodevelopmental disorder, manifests in the first few years of life with developmental arrest, stereotyped behaviors, and respiratory abnormalities. Seizures occur in 70 to 80% of patients. Clinical drug trials have not demonstrated the superiority of any specific antiepilepsy drug. We report our experience with topiramate in eight patients with Rett syndrome. Topiramate was initiated as monotherapy in two patients and as adjunctive therapy in six patients. Seven patients had improved seizure control. Respiratory abnormalities improved by 50 to 75% in two patients and by 20 to 50% in two others. In our cohort, seven of eight patients showed improvement in seizure control and/or respiratory abnormalities on topiramate. Topiramate was well tolerated. The effect of topiramate, a broad-spectrum drug, could be due to its γ-aminobutyric acid (GABA)ergic and glutaminergic effects, both systems thought to be disordered in Rett syndrome. (J Child Neurol 2004;19:588-591).Keywords
This publication has 7 references indexed in Scilit:
- Topiramate Rapidly Raises Brain GABA in Epilepsy PatientsEpilepsia, 2001
- Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsyNeurology, 1999
- Topiramate increases cerebral GABA in healthy humansNeurology, 1998
- Lamotrigine in Rett syndrome: Treatment experience from a pilot studyEuropean Child & Adolescent Psychiatry, 1998
- Topiramate: a review of preclinical, pharmacokinetic, and clinical dataClinical Therapeutics, 1997
- Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brainThe Lancet, 1993
- Intracerebral Microdialysis of Extracellular Amino Acids in the Human Epileptic FocusJournal of Cerebral Blood Flow & Metabolism, 1992